Previous 10 | Next 10 |
Q2 Revenue Up 20% Year-Over-Year, In-Line with Prior Guidance Guiding Record Quarterly Revenue for the March Quarter—Up 18 to 25% Sequentially Growth, Cost Savings Initiatives, CHIPS Act ITC Refund Support Operating Cash Flow Breakeven in December Quarter Robust Cus...
Tier-1 Customer to Use Akoustis’ Next-Generation 5.5 and 6.5 GHz Wi-Fi 7 XBAW ® Filters in 4x4 MIMO Router Platform Secures Wi-Fi 7 Filter Orders to Support Production Ramp in September Quarter of Calendar Year 2024 Charlotte, N.C., Feb. 12, 2024 (GLOBE NEWSWIRE) -...
Tier-1 Customer to Use Multiple Akoustis XBAW ® Filters in 4X4 and 2X2 MU-MIMO Enterprise Access Point Platforms Has Received Volume Orders to Facilitate Production Ramp in the Second Half of Calendar Year 2024 Charlotte, N.C., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Akoustis T...
Charlotte, N.C., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, wi...
VALENCIA, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced that it will report its fourth quarter and f...
Charlotte, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applic...
First BAW Design Win at a Tier-1 Automotive Customer in the Fast-Growing EV Market Segment Based on IC Reference Design by a Leading Semiconductor Supplier Production Expected to Ramp in the March Quarter of Calendar Year 2025 Charlotte, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE...
Board Co-Chair, CEO, CPO, and Other Company Management and Employees Investing $1 Million Charlotte, N.C., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (I...
VALENCIA, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced it has entered...
VALENCIA, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced preliminary un...
News, Short Squeeze, Breakout and More Instantly...
Avianca Holdings S.A. American Depositary Shares (Each representing 8 preferred Shares) Company Name:
AVH Stock Symbol:
NYSE Market:
Tier-1 Customer to Use High-Performance Akoustis XBAW ® Filters for Two Wi-Fi 7 Fixed Wireless Access Enterprise and Home Gateway Platforms Company Has Received Orders to Support Production Ramp Throughout Calendar Year 2024 Charlotte, N.C., May 01, 2024 (GLOBE NEWSWIRE) ...
VALENCIA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its first quarter 2024 financia...
VALENCIA, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced an update to its expected commercial revenue for th...